Side effects of antipsychotics
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Antipsychotics: A Comprehensive Overview
Antipsychotic medications, while essential for managing schizophrenia and other psychotic disorders, are associated with a range of side effects that can significantly impact patient adherence and overall health. This article synthesizes findings from multiple studies to provide a detailed overview of the side effects of antipsychotics, focusing on metabolic, extrapyramidal, and other serious adverse effects.
Metabolic Side Effects of Antipsychotics
Weight Gain and Lipid Changes
One of the most significant metabolic side effects of antipsychotic medications is weight gain. Studies have shown that certain antipsychotics, such as chlorpromazine, clozapine, olanzapine, and zotepine, are particularly associated with substantial weight gain during mid- to long-term treatment1. This weight gain is often accompanied by adverse changes in lipid parameters, including increases in total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides1 5.
Blood Glucose Levels
Antipsychotics can also affect blood glucose levels. Olanzapine, in particular, has been associated with significant increases in fasting glucose levels compared to other antipsychotics and placebo8. This elevation in glucose levels can increase the risk of developing diabetes, making it crucial for clinicians to monitor blood glucose levels in patients on these medications.
Extrapyramidal Side Effects (EPS)
Prevalence and Risk Factors
Extrapyramidal side effects, including drug-induced parkinsonism and tardive dyskinesia, are common complications of antipsychotic treatment. A study involving a community-dwelling sample of patients with schizophrenia found that the prevalence of drug-induced parkinsonism and tardive dyskinesia was 13.2% and 8.3%, respectively4. These side effects were more likely in patients with negative symptoms and those on first-generation antipsychotics4.
Variability Among Patients
The variability in side effects among patients is significant. For instance, weight gain and prolactin levels showed increased variability under antipsychotic treatment, suggesting that some patients may experience more severe side effects than others3. This variability underscores the importance of personalized medicine in the management of schizophrenia.
Other Serious Adverse Effects
Acute and Life-Threatening Events
Antipsychotics can cause serious acute side effects, including myocarditis, agranulocytosis, and neuroleptic malignant syndrome. These life-threatening conditions necessitate careful monitoring and immediate intervention if symptoms arise2 7. A meta-analysis of placebo-controlled trials found that antipsychotics are associated with a higher incidence of somatic serious adverse events, particularly in older patients7.
Sexual and Reproductive Side Effects
Typical antipsychotics can also cause sexual and reproductive side effects, such as sexual dysfunction and menstrual irregularities. These side effects are often dose-dependent and can significantly affect the quality of life and medication adherence10.
Management Strategies
Dose Adjustment and Medication Switch
To manage side effects, clinicians often start by lowering the dose or adjusting the dosing schedule of the antipsychotic. If the side effect persists and is not life-threatening, switching to another antipsychotic with a more favorable side effect profile may be considered2.
Concomitant Medications
In some cases, additional medications may be necessary to manage side effects. For example, anticholinergic medications can be effective for treating dystonias and parkinsonism, while beta-blockers may help with akathisia. Metformin has been shown to aid in weight loss for patients experiencing significant weight gain2.
Conclusion
Antipsychotic medications, while effective in managing psychotic disorders, come with a range of side effects that can impact patient health and treatment adherence. Metabolic side effects, extrapyramidal symptoms, and other serious adverse events are common and vary significantly among patients. Effective management strategies, including dose adjustments, medication switches, and the use of concomitant medications, are essential to optimize treatment outcomes and improve patient quality of life.
Sources and full results
Most relevant research papers on this topic
Metabolic side effects in persons with schizophrenia during mid‐ to long‐term treatment with antipsychotics: a network meta‐analysis of randomized controlled trials
Antipsychotic drugs differ in their propensity to induce metabolic side effects in mid- to long-term treatment for schizophrenia.
Meta-AnalysisManagement of common adverse effects of antipsychotic medications
Managing common side effects of antipsychotic medications can optimize net benefits and minimize adverse effects.
Highly CitedExamining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.
Antipsychotic side effects in schizophrenia spectrum disorders show increased variability, suggesting stratified or personalized medicine may be beneficial for subgroups or individual patients.
Meta-Analysis
Rigorous JournalPrevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Extrapyramidal side effects are highly prevalent in community-dwelling schizophrenia patients, with risk factors including negative symptoms, disorganization, and cognitive alteration.
Meta-AnalysisHead-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Some second-generation antipsychotics cause more metabolic side effects than others, requiring careful consideration when choosing a treatment for individual patients.
Meta-AnalysisHighly CitedAntipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Antipsychotics primarily target striatal dopamine D2 receptors, but new treatments targeting dopamine synthesis and storage may improve efficacy and reduce side-effects.
Rigorous JournalHighly CitedSecond-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis.
Second-generation antipsychotic drugs may cause short-term somatic serious adverse events, with larger effects in older patients and those with severe mental health disorders.
Meta-AnalysisRigorous JournalThe metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis
Olanzapine is associated with significantly higher blood glucose levels than other antipsychotic drugs, helping clinicians tailor drug choices to individual patient needs.
Meta-AnalysisRigorous JournalHighly CitedAntipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies
Antipsychotic-induced extrapyramidal side effects are highly prevalent, with one in five and more than one in ten patients experiencing parkinsonism and akathisia, respectively.
Meta-AnalysisRigorous JournalAn overview of side effects caused by typical antipsychotics.
Typical antipsychotics can cause side effects ranging from annoying to disabling, and potentially fatal, affecting every system of the body.
Highly Cited